Clinical value of whole-body positron emission tomography in potentially curable colorectal liver metastases
- 1 March 2001
- journal article
- research article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 27 (2), 175-179
- https://doi.org/10.1053/ejso.2000.1075
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Additional Value of Whole-Body Positron Emission Tomography With Fluorine-18-2-Fluoro-2-deoxy-d-glucose in Recurrent Colorectal CancerJournal of Clinical Oncology, 1999
- FDG Accumulation and Tumor BiologyNuclear Medicine and Biology, 1998
- Clinical evaluation of whole-body 18F-fluorodeoxyglucose positron emission tomography in the detection of liver metastasesAnnals of Oncology, 1998
- THE APPROACH TO THE PATIENT WITH SINGLE AND MULTIPLE LIVER METASTASES, PULMONARY METASTASES, AND INTRA-ABDOMINAL METASTASES FROM COLORECTAL CARCINOMAHematology/Oncology Clinics of North America, 1997
- The Miniscule Benefit of Serial Carcinoembryonic Antigen Monitoring After Effective Curative Treatment for Primary Colorectal CancerJournal of the American College of Surgeons, 1997
- Liver metastases from colorectal cancer: Lessons from past and present clinical studiesBritish Journal of Surgery, 1996
- Patient selection and treatment of peritoneal carcinomatosis from colorectal and appendiceal cancerWorld Journal of Surgery, 1995
- Follow‐up plans after treatment of primary colon and rectum cancerWorld Journal of Surgery, 1991
- Intra-abdominal extrahepatic disease in patients with colorectal hepatic metastasesDiseases of the Colon & Rectum, 1988
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958